BioXcel Therapeutics’ Stock Dips on Proposed Public Offering
In the world of biopharmaceuticals, where innovation and cutting-edge technology intersect, BioXcel Therapeutics stands as a notable player leveraging artificial intelligence to revolutionize medicine. Today,